MindBio Therapeutics CEO Demonstrates how 1 Million Microdoses of LSD can Potentially be Used to Treat Depression at Scale

1 Million Microdoses used by MindBio to create proprietary microdosing formulationMindBio scientists take delivery of GMP grade LSDLargest clinical trial repository of biometric, physiological and psychometric

Related Keywords

Canada ,Australia ,Vancouver ,British Columbia ,Canadian ,Justin Hanka ,Mindbio Therapeuticsview ,Neither The Canadian Securities Exchange ,Company Or Mindbio ,Regulation Service Provider ,Mindbio Therapeutics Corp ,Mindbio Therapeutics ,Chief Executive Officer Justin Hanka ,Good Manufacturing Practices ,Canadian Government ,Executive Officer ,Bio Therapeutics ,Bio Co Founder ,Chief Executive Officer ,Chief Executive ,Lysergic Acid Diethylamide ,Major Depressive Disorder ,Note Concerning Forward Looking Statements ,Canadian Securities Exchange ,Gefallene Big Techs ,Mindbio ,Herapeutics ,Emonstrates ,Billion ,Microdoses ,Potentially ,Ased ,Treat ,Depression ,Scale ,